Im Cannabis Corp Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT b Read MoreIm Cannabis Corp is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.
Im Cannabis Corp
Score
Reported Results
No latest earnings report cached yet
Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.
Recent News
Earnings Per Share
Score 1.00/5
Im Cannabis Corp earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Drug Manufacturers Specialty & Generic industry
, Zoetis Inc
, Amphastar P
, Prestige Consumer Healthcare
are companies with high ratings.
Return on Equity
Score 1.95/5
Im Cannabis Corp exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
Metric chart temporarily unavailable.
Net Margin
Score 2.21/5
Im Cannabis Corp
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
Metric chart temporarily unavailable.
Leverage
Score 1.44/5
Im Cannabis Corp
registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
have achieved high scores.
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
SEC financial statements are temporarily unavailable.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios